Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data

Objective To use the rs1229984 variant in the alcohol dehydrogenase 1B gene (ADH1B) as an instrument to investigate the causal role of alcohol in cardiovascular disease. Design Mendelian randomisation meta-analysis of 56 epidemiological studies. Participants 261 991 individuals of European descent, including 20 259 coronary heart disease cases and 10 164 stroke events. Data were available on ADH1B rs1229984 variant, alcohol phenotypes, and cardiovascular biomarkers. Main outcome measures Odds ratio for coronary heart disease and stroke associated with the ADH1B variant in all individuals and by categories of alcohol consumption. Results Carriers of the A-allele of ADH1B rs1229984 consumed 17.2% fewer units of alcohol per week (95% confidence interval 15.6% to 18.9%), had a lower prevalence of binge drinking (odds ratio 0.78 (95% CI 0.73 to 0.84)), and had higher abstention (odds ratio 1.27 (1.21 to 1.34)) than non-carriers. Rs1229984 A-allele carriers had lower systolic blood pressure (−0.88 (−1.19 to −0.56) mm Hg), interleukin-6 levels (−5.2% (−7.8 to −2.4%)), waist circumference (−0.3 (−0.6 to −0.1) cm), and body mass index (−0.17 (−0.24 to −0.10) kg/m2). Rs1229984 A-allele carriers had lower odds of coronary heart disease (odds ratio 0.90 (0.84 to 0.96)). The protective association of the ADH1B rs1229984 A-allele variant remained the same across all categories of alcohol consumption (P=0.83 for heterogeneity). Although no association of rs1229984 was identified with the combined subtypes of stroke, carriers of the A-allele had lower odds of ischaemic stroke (odds ratio 0.83 (0.72 to 0.95)). Conclusions Individuals with a genetic variant associated with non-drinking and lower alcohol consumption had a more favourable cardiovascular profile and a reduced risk of coronary heart disease than those without the genetic variant. This suggests that reduction of alcohol consumption, even for light to moderate drinkers, is beneficial for cardiovascular health.

Hynek Pikhart | Tom R. Gaunt | Meena Kumari | Rebecca Hardy | Shah Ebrahim | Tom M Palmer | Debbie A Lawlor | Frank Dudbridge | Bonnie Spring | Eric Boerwinkle | Michael V Holmes | Olle Melander | Tom R Gaunt | Pamela J Schreiner | Yiran Guo | Jorgen Engmann | Juan P Casas | Andrew D. Johnson | Nicholas J Wareham | Per Eriksson | Lars Lannfelt | Martin Bobak | Bruce M Psaty | Philippa J Talmud | Lasse Folkersen | Susan Redline | Heiner Boeing | Ajay Yesupriya | Abdonas Tamosiunas | Allan Linneberg | Claudia Langenberg | Børge G Nordestgaard | Leon Flicker | Irene Mateo Leach | Elina Hyppönen | Diana Kuh | Albert Hofman | James Y Dai | Charles Kooperberg | James Y. Dai | Peter H Whincup | Hakon Hakonarson | Martin Farrall | Stella Trompet | J Wouter Jukema | Myriam Fornage | Andrzej Pajak | Sandosh Padmanabhan | Tina Shah | Ruzena Kubinova | George Davey Smith | Pim A de Jong | Mika Kivimaki | Andrew D Johnson | David Prieto-Merino | Sonia Shah | Abbas Dehghan | Oscar H Franco | Kay-Tee Khaw | Stela McLachlan | Anne Peasey | L Adrienne Cupples | Alex P Reiner | Jutta Palmen | Pedro Marques-Vidal | Andrew N Nicolaides | Anke H Maitland-van der Zee | Fulvio Ricceri | Anders Hamsten | Josef Coresh | Pim van der Harst | Sanjay R Patel | Folkert W Asselbergs | Robert A Scott | John Whittaker | Alana Cavadino | Andrea Z LaCroix | Naveed Sattar | Eric Jorgenson | M Arfan Ikram | Pieter A Doevendans | M. Fornage | Sonia Shah | O. Franco | A. Hofman | A. Uitterlinden | A. LaCroix | A. Reiner | E. Rimm | D. Lawlor | S. Redline | H. Hakonarson | E. Boerwinkle | B. Spring | A. Dominiczak | M. Farrall | G. Hankey | Yiran Guo | P. D. de Bakker | S. Humphries | C. Kooperberg | A. Hingorani | J. Ferro | A. Dehghan | J. Coresh | A. Tjønneland | B. Psaty | D. Siscovick | P. Talmud | P. Whincup | N. Sattar | M. Marmot | O. Melander | J. Rotter | J. Whittaker | S. Sharp | N. Wareham | B. Nordestgaard | A. Hamsten | E. Hyppönen | C. Power | P. Eriksson | L. Cupples | F. Ricceri | A. Nicolaides | J. Jukema | S. Ebrahim | W. Spiering | F. Dudbridge | M. Ikram | H. Watkins | James G. Wilson | L. Lannfelt | S. Padmanabhan | R. Scott | C. Langenberg | P. Schreiner | P. van der Harst | C. Kooperberg | N. Dowling | Ajay Yesupriya | T. Meade | L. Folkersen | J. Price | K. Khaw | A. Wong | M. Kumari | M. Kivimaki | D. Kuh | G. Davey Smith | J. Jukema | M. Bobák | H. Boeing | J. Casas | R. Hardy | R. Kubínová | A. Linneberg | S. Malyutina | S. McLachlan | A. Pająk | H. Pikhart | A. Tamosiunas | J. Tolstrup | W. Verschuren | P. Norman | I. M. Leach | S. Trompet | P. D. de Jong | N. Verweij | I. Ford | F. Asselbergs | L. Lange | M. Holmes | T. Skaaby | A. Cavadino | R. Morris | L. Husemoen | S. Wannamethee | M. Bergmann | N. Onland-Moret | C. Sacerdote | Y. Li | D. Prieto-Merino | M. Lanktree | R. Ellison | J. Cooper | T. Palmer | B. Keating | C. Weikert | O. Klungel | E. Jorgenson | L. Flicker | O. Almeida | K. Kuchenbaecker | S. Borinskaya | M. Voevoda | J. Tolstrup | M. Hofker | M. Leusink | C. Finan | J. Palmen | A. Panayiotou | J. Hubacek | V. Adámková | J. Beulens | J. Meschia | A. H. Maitland‐van der Zee | S. Buxbaum | F. V. van Bockxmeer | P. Doevendans | D. Leon | K. Mukamal | O. Ross | M. Cramer | W. Verschuren | Shanshan Li | A. Peasey | A. Hamidovic | L. Zuccolo | R. Silverwood | C. Dale | T. Shah | D. Drogan | J. Engmann | D. Swerdlow | R. Hoogeveen | M. Tsai | Dale M. Gamble | A. Vicente | Osvaldo P Almeida | David A Leon | Paul I W de Bakker | David S Siscovick | Niek Verweij | Anne Tjønneland | Maarten J Cramer | Graeme J Hankey | Ian Ford | Michael G Marmot | Yun R Li | Manuela M Bergmann | Matthew B Lanktree | Jerome I Rotter | Andre G Uitterlinden | Carlotta Sacerdote | Aroon D Hingorani | M. Cramer | Astrid M Vicente | Richard Morris | Hugh Watkins | Tea Skaaby | James G Wilson | Steve E Humphries | Owen A Ross | Marten H Hofker | S Goya Wannamethee | Andrew Wong | Olaf H Klungel | Shanshan Li | Ron C Hoogeveen | Paul E Norman | Sarah G Buxbaum | Michael Y Tsai | Eric Rimm | Zheng Ye | Andrie G Panayiotou | Jaroslav A Hubacek | Vera Adamkova | Anna F Dominiczak | Brendan J Keating | I. Sluijs | Janne S Tolstrup | Tom Meade | Mikhail I Voevoda | Z. Ye | Leslie A Lange | Chris Finan | Jackie F Price | Nicole F Dowling | Karoline B Kuchenbaecker | N Charlotte Onland-Moret | Daniel I Swerdlow | Wilko Spiering | Sruti Rayaprolu | Stephen J Sharp | Dagmar Drogan | Cornelia Weikert | Luisa Zuccolo | W M Monique Verschuren | P. Doevendans | J. Sundstrom | Joline W J Beulens | James Meschia | Christine Power | Sofia Malyutina | Jackie Cooper | Kenneth Mukamal | Ajna Hamidovic | Frank M van Bockxmeer | Jose M Ferro | Johan Sundstrom | Maarten Leusink | Caroline E Dale | Richard J Silverwood | Svetlana A Borinskaya | Dale M Gamble | Olga Vikhireva | Ivonne Sluijs | Sofia Paulos-Pinheiro | Lise Lotte N Husemoen | R Curtis Ellison | S. Rayaprolu | Steve E. Humphries | A. Johnson | Drogan | B. Spring | O. Vikhireva | S. Patel | RichardJ. Morris | K. Mukamal | S. G. Wannamethee | I. Ford | P. Marques-Vidal | P. van der harst | S. Paulos-Pinheiro | D. Lawlor | A. Tamošiūnas | J. M. Ferro | Sonia H. Shah | J. Coresh | A. Uitterlinden | B. Psaty | Elina Hyppönen | M. A. Ikram | Dagmar | Anders Hamsten | Jackie A. Cooper | Graeme J. Hankey | Andrew N. Nicolaides | Jerome I. Rotter | Albert Hofman | Shah Ebrahim | Michael G Marmot | Per Eriksson | David A Leon | Robert A. Scott | Oscar H. Franco | Michael V. Holmes | Yiran Guo | Zheng Ye | David Prieto-Merino | Shanshan Li | Sonia Shah | Per Eriksson | Owen A Ross | Tom Meade | S. Ebrahim | Jackie F Price | Anke H Maitland-van der Zee | Paul E Norman | Osvaldo P. Almeida | Hugh Watkins | Stephen J. Sharp | Andrea Z LaCroix | R. C. Ellison | Sanjay R Patel | John C. Whittaker | Jackie F. Price | R. Ellison | Jackie F. Price | M. Marmot | Owen A. Ross | Sanjay R. Patel | Nicole F. Dowling | D. Prieto-Merino | Jackie A. Cooper | S. G. Wannamethee | Tom W Meade | J. Rotter | J. Ferro | Sruti Rayaprolu

[1]  S G Thompson,et al.  Investigating underlying risk as a source of heterogeneity in meta-analysis. , 1997, Statistics in medicine.

[2]  R. Room Smoking and drinking as complementary behaviours. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  H. V. van Houwelingen,et al.  Investigating underlying risk as a source of heterogeneity in meta-analysis. , 1999, Statistics in medicine.

[4]  Mark I. McCarthy,et al.  Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies , 2008, PloS one.

[5]  Tanya M. Teslovich,et al.  The Metabochip, a Custom Genotyping Array for Genetic Studies of Metabolic, Cardiovascular, and Anthropometric Traits , 2012, PLoS genetics.

[6]  N Slimani,et al.  Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011, Diabetologia.

[7]  D. Lawlor,et al.  Cohort Profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort , 2012, International journal of epidemiology.

[8]  Tom R. Gaunt,et al.  Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. , 2012, American journal of human genetics.

[9]  Jack Darkes,et al.  The validity of self-reports of alcohol consumption: state of the science and challenges for research. , 2003, Addiction.

[10]  T. Babor Ethics matter: to authors, editors and those we serve. , 2003, Addiction.

[11]  D. Lawlor,et al.  Cohort Profile: The ‘Children of the 90s’—the index offspring of the Avon Longitudinal Study of Parents and Children , 2012, International journal of epidemiology.

[12]  R. Jackson,et al.  Alcohol and ischaemic heart disease: probably no free lunch , 2005, The Lancet.

[13]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[14]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[15]  J. Robins,et al.  Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions. , 2012, American journal of epidemiology.

[16]  A. G. Shaper,et al.  ALCOHOL AND MORTALITY IN BRITISH MEN: EXPLAINING THE U-SHAPED CURVE , 1988, The Lancet.

[17]  Tien Yin Wong,et al.  Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians , 2011, Nature Genetics.

[18]  H. Edenberg The Genetics of Alcohol Metabolism: Role of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Variants , 2007, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[19]  Stefan N. Willich,et al.  Alcohol Consumption, Genetic Variants in Alcohol Deydrogenases, and Risk of Cardiovascular Diseases: A Prospective Study and Meta-Analysis , 2012, PloS one.

[20]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[21]  B. Pannier,et al.  Relationship between alcohol intake, health and social status and cardiovascular risk factors in the urban Paris-Ile-De-France Cohort: is the cardioprotective action of alcohol a myth? , 2010, European Journal of Clinical Nutrition.

[22]  L. Garfinkel,et al.  Alcohol Drinking and Mortality among Men Enrolled in an American Cancer Society Prospective Study , 1990, Epidemiology.

[23]  S. Lewis,et al.  Alcohol Intake and Blood Pressure: A Systematic Review Implementing a Mendelian Randomization Approach , 2008, PLoS medicine.

[24]  T. Hansen,et al.  The Association of Alcohol and Alcohol Metabolizing Gene Variants with Diabetes and Coronary Heart Disease Risk Factors in a White Population , 2010, PLoS ONE.

[25]  M. Freiberg,et al.  Alcohol and coronary heart disease: the answer awaits a randomized controlled trial. , 2005, Circulation.

[26]  G Corrao,et al.  Alcohol and coronary heart disease: a meta-analysis. , 2000, Addiction.

[27]  S. Higuchi,et al.  Blood ethanol levels of nonabstinent Japanese alcoholic men in the morning after drinking and their ADH1B and ALDH2 genotypes. , 2014, Alcohol and Alcoholism.

[28]  Tatiana Foroud,et al.  ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry , 2011, Molecular Psychiatry.

[29]  D. Lawlor,et al.  Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population Study. , 2013, European heart journal.

[30]  W. Ghali,et al.  Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis , 2011, BMJ : British Medical Journal.

[31]  Nuala A Sheehan,et al.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure , 2005, Statistics in medicine.

[32]  Gordon H Guyatt,et al.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis , 2009, BMJ : British Medical Journal.

[33]  N. Martin,et al.  Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. , 2009, Human molecular genetics.

[34]  S. Popova,et al.  The relation between different dimensions of alcohol consumption and burden of disease: an overview. , 2010, Addiction.

[35]  Gower Street,et al.  Health inequalities among British civil servants: the Whitehall II study , 1991, The Lancet.

[36]  Markus Abt,et al.  Effects of dalcetrapib in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[37]  B. Nordestgaard,et al.  Alcohol Intake, Myocardial Infarction, Biochemical Risk Factors, and Alcohol Dehydrogenase Genotypes , 2009, Circulation. Cardiovascular genetics.

[38]  J. O’Keefe,et al.  Alcohol and cardiovascular health: the razor-sharp double-edged sword. , 2007, Journal of the American College of Cardiology.

[39]  W. Ghali,et al.  Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies , 2011, BMJ : British Medical Journal.

[40]  A. Hingorani,et al.  Nature's randomised trials , 2005, The Lancet.